GRAMD1B and leukemia: At our hospital, low-dose LAMB is the drug of choice for AF prophylaxis in high-risk cancer patients (relapsed or refractory leukaemia, HSCT pre-engraftment phase) due to its effectiveness and safety profile as shown in a previous paper by our group [16].